We investigated the relationships among serum testosterone levels, body fat and muscle mass distribution in women with polycystic ovary syndrome (PCOS).
RECENT evidence indicates that abnormal body fat distribution rather than overall adiposity (i.e., obesity) is associated with the occurrence of various endocrine and metabolic abnormalities, including insulin resistance, diabetes mellitus, hypertension, and atherosclerosis.
Women with upper body fat distribution are sometimes described as "android women". In fact, upper body fat distribution is associated with serum androgen levels [1 , 2] . Android women have higher bone mineral density, and greater muscle mass, as observed in men [3, 4] . Body fat mass and muscle mass have a reciprocal relationship to each other [5] . However, relationships among body fat distribution, muscle mass distribution, and serum androgen levels have not been explored extensively.
PCOS, one of the most common endocrine disorders in reproductive-aged women, involves menstrual disturbances, chronic anovulation, insulin resistance, and hyperandrogenism [6, 7] . In the present study, we investigated the relationship among serum androgen levels, body fat distribution, and muscle mass distribution in women with PCOS. DOUCHI et al.
Materials and Methods
Fully informed consent was obtained in accordance with institutional guidelines. The study was also conducted in accordance with the provisions of the Declaration of Helsinki. We encountered 75 reproductive-aged amenorrheic women with PCOS at the Infertility and Endocrinology Clinic, Kagoshima University Hospital, between May 1997 and April 2000. Exclusion criteria were excess alcohol consumption (n = 2), cigarette smoking (n = 2), either previous or current oral contraceptive usage (n = 3), and physical endurance training (n = 3); some cases were excluded for multiple reasons. The remaining subjects were 67 PCOS women between 20-38 years of age (mean±standard deviation, 28.0±6.7 years). None of the PCOS patients demonstrated any evidence of androgen-secreting neoplasm, pituitary adenoma, homozygous adrenal hyperplasia, acromegaly or Cushing's syndrome. None of the subjects were taking any medication likely to affect muscle size, muscle strength, or body fat distribution. All subjects showed progestin-induced withdrawal bleeding (dydrogesterone 10 mg orally daily for 5 days). All patients were evaluated without regard to menstrual cycle since all were amenorrheic. Criteria for PCOS were as follows: 1) the presence of chronic oligomenorrhea (six or fewer menses per year) or amenorrhea, 2) elevated serum levels of LH with normal FSH and LH/FSH at least 1.5, and 3) polycystic ovarian ultrasound appearance defined by the presence of ten or more follicles 2-8 mm in diameter with a tendency toward peripheral distribution and bright echodense stroma [8] . Each subject demonstrated normal prolactin (PRL) levels.
Baseline characteristics included age and height. Serum testosterone and dehydroepiandrosterone sulfate (DHEAS) levels were measured by commercially available radioimmunoassay (RIA) with Total Testosterone Kit and DHEAS Kit (Diagnostic Product Corp., Los Angeles, CA, USA), respectively. The intra-assay and interassay coefficients of variation for these RIAs were 3-5% and 8-10%, respectively. The ratios of trunk fat mass to leg fat mass (trunk-leg fat ratio) and the ratios of trunk muscle mass to leg muscle mass (trunk-leg muscle ratio) were assessed by whole-body scanning with dual-energy x-ray absorptiometry. The major component of lean mass assessed by dual-energy x-ray absorptiometry is muscle mass. Muscle mass measurements do not include bone mineral content. Trunk muscle mass and leg muscle mass were determined by repeated measurements in six volunteers over 8 weeks. Precision of these two measurements was indicated by coefficients of variation that were all less than 4%. Dual-energy x-ray absorptiometry measurements were performed between 9 : 00 AM and 12 : 00 PM with a total body scanner (QDR 2,000/W, Hologic Inc., Waltham, MA, USA) and results were evaluated by the same examiner. This equipment uses switched pulsed stable dual-energy radiation with kilovoltages of 70 and 140. The machine performs serial transverse scans from head to toe at 1.2-cm intervals and provides a pixel size of 1.9 mm x 1.2 mm. The radiation dose is 0.05-0.15 pGy. Default software readings divided body measurements into areas corresponding to arm, trunk, and leg. The trunk region was delineated by an upper horizontal border below the chin, vertical borders lateral to the ribs, and a lower border formed by oblique lines passing through the hip joints. The leg region was defined as tissue below the oblique line passing through the hip joint. All recordings were performed by the same experienced investigator. The examiner was masked to the study status.
All variables were distributed normally. Correlations between the two variables were investigated using Pearson correlation and partial correlation tests. Confidence intervals (CI) for the correlations and prediction intervals were calculated to evaluate the accuracy of the regressions. P<0.05 was considered significant. Table 1 presents baseline characteristics, anthropometric variables, and serum androgen levels in women with PCOS. Table 2 presents the outcome of Pearson correlation test. Serum testosterone levels were positively correlated with trunk-leg fat ratio (r=0.398, P< 0.01), but were inversely correlated with trunk-leg muscle ratio (r= -0.332, P<0.05).
Results
Trunk-leg muscle ratio was inversely correlated with trunk-leg fat ratio (r= -0.360, P<0.01). However, serum DHEAS levels were not correlated with trunk-leg fat ratio or trunk-leg muscle ratio.
Thus, DHEAS was excluded from the following partial correlation test. Table 3 presents the outcome of partial correlation test. Serum testosterone levels were still correlated with trunk-leg fat ratio (r= 0.500, P < 0.001) and trunk-leg muscle ratio (r= -0.286, P <0.05) after adjusting for age and height. Trunk-leg fat ratio was correlated with trunk-leg muscle ratio after adjusting for age and height (r= -0.349, P<0.001). This relationship was still significant after increasing serum testosterone levels to adjust the variables.
Discussion
In the present study, we found that serum testosterone levels are positively correlated with trunk-leg fat ratio, but are inversely correlated with trunk-leg muscle ratio. However, such relationships were not observed for serum DHEAS levels. There are several factors contributing to the shift toward upper body fat distribution.
These include changes in energy intake, decreased strength, changes in sex steroid or certain hormonal factors [9] . Upper body fat distribution is frequently observed in women with PCOS.
Upper body fat distribution in women with PCOS has mainly been explained by androgen excess [2, 3, 10] because testosterone inhibits femoral lipoprotein lipase activity [11] . Menopause-related shift Table   1 . Baseline characteristics, anthropometric variables, and serum androgen levels in women with PCOS (n=67) toward upper body fat distribution has mainly been explained by estrogen deficiency [12] [13] [14] because estrogens influence gluteofemoral adiposity, as evidenced by preferential gluteofemoral fat deposit with the pubertal onset of ovarian function [15, 16] . Lipoprotein lipase activity in reproductive-aged women is greater in gluteofemoral adipose tissue than in abdominal adipose tissue [15, 16] . Thus, estrogen and testosterone play a reciprocal role in the regulation of fat deposit in the leg and abdominal regions. Body fat and muscle mass have a reciprocal relationship to each other [5] . In the segmental regions as well as the whole body, the greater the increase in muscle mass, the greater the decrease in fat mass.
In the present study, trunk-leg muscle ratio was inversely correlated with trunk-leg fat ratio. Thus, peripheral muscle mass distribution may in part contribute to upper body fat distribution in women with PCOS.
As to why peripheral muscle mass distribution associated with serum testosterone levels, it is well known that androgens have been used to increase muscle size and strength [17] [18] [19] [20] . Testosterone increases muscle fibers. Danazol, 17-a ethinyl testosterone, also induces striking changes in body composition (i.e., significant increase in muscle mass but decrease in body fat mass) in patients with endometriosis [21] . However, it remains unclear as to whether the increase in muscle size during testosterone administration or in the androgenic environment is uniformly observed at various sites of segmental regions. In view of this, we calculated the changes in trunk-leg muscle ratio from the report by Bruce et al. [21] , and found that trunk-leg muscle ratio decreased 6 months after danazol therapy. Elbers et al. [22] reported that muscle area at the thigh level increased significantly by 12.6 ± 7.6% from the baseline one year after the administration of testosterone in young female to male transsexuals.
There is also a report indicating that women treated with androgen gained muscle mass despite overall weight loss, and that this result was mainly attributable to a significant increase in midthigh muscle area [23] . These observations suggest that androgen enhances muscle size in the leg more than that in the trunk.
Muscle mass is also influenced by physical exercise.
Humans are always using their bilateral legs and arms to stand, walk, and handle things. Naturally, physical exercise in daily life is greater in the extremities than in the trunk.
Thus, it is speculated that higher serum testosterone levels in women with PCOS cause a shift toward peripheral muscle mass distribution.
However, it appears that an inverse relationship between trunk-leg muscle and fat ratio is not specific in women with PCOS, but common in androgenic women despite presence or absence of menstruation.
There is a report indicating that higher appendicular muscle mass, skeletal mass, and upper body fat distribution are associated with greater androgenic activity in healthy women [24] . Second, upper body fat distribution, as in PCOS women, is also associated with insulin resistance and hyperinsulinemia [25] . The effect of hyperinsulinemia on muscle mass distribution should be taken into consideration.
Although we did not measure serum insulin levels in the present study, there is a report that fasting insulin levels did not show any significant correlation with the measurement of muscle mass [26] . Thus, to date, peripheral muscle mass distribution in PCOS women cannot be explained by serum insulin levels. Based on these results, we concluded that higher serum testosterone levels may contribute to the upper body fat distribution and peripheral muscle mass distribution.
In addition, peripheral muscle mass distribution may also contribute to upper body fat distribution.
